Teva offers colossal $23.3B opioid 'framework' deal to escape thousands of lawsuits

Instead of facing the courtroom in an Ohio bellwether opioid trial, Teva is opting to bow out with a $45 million settlement with two counties. But that's just one piece of a much bigger deal in the works.

Teva is seeking to opt out of all its opioid suits to the tune of $250 million in cash and $23 billion in free drugs.